Abstract:Objective To study the effect of curcumin on miR-211 in colon cancer cells and clarify a miR-211-mediated mechanism which plays a role in the anti-tumor effects of curcumin. Methods The dose-effect and time-effect relationship of curcumin on HCT116 was tested by MTT assay and flow cytometry. Expression level of miR-211 in curcumin-treated HCT116 was detected by qRT-PCR. TP53INP1 was predicted as a target of miR-211 using GeneTarget database and confirmed by dual luciferase reporter assays. Additionally, the effect of upregulating miR-211 by miR-211 mimics or silencing TP53INP1 by siRNA on curcumin-treated HCT116 was examed by MTT and flow cytometry. Results Compared with untreated HCT116 cells, curcumin at 10-50 μmol/L inhibited cell proliferation and induced apoptosis in a dose-dependent and time-dependent manner. Curcumin also produced a dose and time dependent suppression of miR-211 (P < 0.05). Moreover, the protein level of TP53INP1 was significantly elevated in crucumin-treated HCT116 cells (P < 0.05). Transfection of HCT116 with miR-211 mimics or TP53INP1 small interfering RNA significantly reversed the effect of curcumin on HCT116, compared to corresponding controls (P < 0.05). Conclusions Our data suggest a novel molecular mechanism in which inhibition of miR-211 and upregulation of TP53INP1 mediate the anticancer activities of curcumin in colon cancer cells.